PubMed for id: 9390

Year	Number of Results
1998	1
1999	2
2002	1
2004	1
2005	1
2006	1
2008	2
2009	3
2010	1
2013	1
2014	3
2015	1
2017	1
2019	1
2020	1
2021	2
2022	2
2024	1

1

Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels.

Higashino T, Morimoto K, Nakaoka H, Toyoda Y, Kawamura Y, Shimizu S, Nakamura T, Hosomichi K, Nakayama A, Ooyama K, Ooyama H, Shimizu T, Ueno M, Ito T, Tamura T, Naito M, Nakashima H, Kawaguchi M, Takao M, Kawai Y, Osada N, Ichida K, Yamamoto K, Suzuki H, Shinomiya N, Inoue I, Takada T, Matsuo H. Higashino T, et al. Ann Rheum Dis. 2020 Jan;79(1):164-166. doi: 10.1136/annrheumdis-2019-216044. Epub 2019 Nov 28. Ann Rheum Dis. 2020. PMID: 31780526 Free PMC article. No abstract available.

2

Isolation and characterization of the anticancer gene organic cation transporter like-3 (ORCTL3).

AbuAli G, Grimm S. AbuAli G, et al. Adv Exp Med Biol. 2014;818:213-27. doi: 10.1007/978-1-4471-6458-6_11. Adv Exp Med Biol. 2014. PMID: 25001539 Review.

3

Functional coupling of organic anion transporter OAT10 (SLC22A13) and monocarboxylate transporter MCT1 (SLC16A1) influencing the transport function of OAT10.

Ohtsu N, Ohgaki R, Jin C, Xu M, Okanishi H, Takahashi R, Matsui A, Kishimoto W, Ishiguro N, Kanai Y. Ohtsu N, et al. J Pharmacol Sci. 2022 Sep;150(1):41-48. doi: 10.1016/j.jphs.2022.06.003. Epub 2022 Jun 17. J Pharmacol Sci. 2022. PMID: 35926947 Free article.

4

Functional characterization of human organic anion transporter 10 (OAT10/SLC22A13) as an orotate transporter.

Shinoda Y, Yamashiro T, Hosooka A, Yasujima T, Yuasa H. Shinoda Y, et al. Drug Metab Pharmacokinet. 2022 Apr;43:100443. doi: 10.1016/j.dmpk.2021.100443. Epub 2021 Dec 23. Drug Metab Pharmacokinet. 2022. PMID: 35144162

5

SLC22A13 catalyses unidirectional efflux of aspartate and glutamate at the basolateral membrane of type A intercalated cells in the renal collecting duct.

Schulz C, Fork C, Bauer T, Golz S, Geerts A, Schömig E, Gründemann D. Schulz C, et al. Biochem J. 2014 Jan 15;457(2):243-51. doi: 10.1042/BJ20130654. Biochem J. 2014. PMID: 24147638

6

Isolation of ORCTL3 in a novel genetic screen for tumor-specific apoptosis inducers.

Irshad S, Mahul-Mellier AL, Kassouf N, Lemarie A, Grimm S. Irshad S, et al. Cell Death Differ. 2009 Jun;16(6):890-8. doi: 10.1038/cdd.2009.21. Epub 2009 Mar 13. Cell Death Differ. 2009. PMID: 19282870 Free PMC article.

7

Identification of a new urate and high affinity nicotinate transporter, hOAT10 (SLC22A13).

Bahn A, Hagos Y, Reuter S, Balen D, Brzica H, Krick W, Burckhardt BC, Sabolic I, Burckhardt G. Bahn A, et al. J Biol Chem. 2008 Jun 13;283(24):16332-41. doi: 10.1074/jbc.M800737200. Epub 2008 Apr 14. J Biol Chem. 2008. PMID: 18411268 Free article.

8

Examining the Association of Rare Allelic Variants in Urate Transporters SLC22A11, SLC22A13, and SLC17A1 with Hyperuricemia and Gout.

Vávra J, Pavelcová K, Mašínová J, Hasíková L, Bubeníková E, Urbanová A, Mančíková A, Stibůrková B. Vávra J, et al. Dis Markers. 2024 Jan 6;2024:5930566. doi: 10.1155/2024/5930566. eCollection 2024. Dis Markers. 2024. PMID: 38222853 Free PMC article.

9

Molecular cloning, mapping, and characterization of two novel human genes, ORCTL3 and ORCTL4, bearing homology to organic-cation transporters.

Nishiwaki T, Daigo Y, Tamari M, Fujii Y, Nakamura Y. Nishiwaki T, et al. Cytogenet Cell Genet. 1998;83(3-4):251-5. doi: 10.1159/000015197. Cytogenet Cell Genet. 1998. PMID: 10072596

10

Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3.

Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E, Nakamura Y. Daigo Y, et al. Cancer Res. 1999 Apr 15;59(8):1966-72. Cancer Res. 1999. PMID: 10213508

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year